|
Index of reports
> Cases resulting in a serious event (294)
> Cases with Blood Creatine Phosphokinase Increased (30)
Below is the selection of adverse event reports related to Zetia (Ezetimibe) that includes cases resulting in a serious event where reactions include blood creatine phosphokinase increased.
Reports 1 - 25 of 30 Next >>
Adverse event in 60 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-26
Patient: 60 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Hepatic Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Ursodiol; Phospholipids (Unspecified); Allopurinol; Pioglitazone Hydrochloride; Amlodipine Besylate
Adverse event in 40 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-10-18
Patient: 40 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Aldolase Increased
Suspect drug(s):
Crestor
Administration route: Oral
Zetia
Other drugs received by patient: Unspecified Beta Blocker
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-10-17
Patient: male, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Weight Decreased, Blood Creatine Phosphokinase Increased, Muscle Atrophy, Muscle Contractions Involuntary, Fear, Myalgia, Facial Paresis, Joint Range of Motion Decreased, Amyotrophic Lateral Sclerosis, Blood Cholesterol Increased, Dyspnoea, Pain in Extremity, Chromaturia, Anxiety, Hyperphagia, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypercholesterolaemia
Lipitor
Indication: Blood Cholesterol Increased
Zetia
Other drugs received by patient: Norvasc; Metoprolol
Adverse event in 72 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-10-12
Patient: 72 year old male, weighing 74.8 kg (164.7 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Musculoskeletal Pain, Cognitive Disorder, Myalgia, Fatigue, Gait Disturbance, Muscle Spasms, Pain in JAW
Suspect drug(s):
Crestor
Dosage: 5mgm daily po
Administration route: Oral
Start date: 2007-10-02
End date: 2007-10-09
Zetia
Dosage: 10 mgm daily po
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-04-10
End date: 2006-09-02
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-07-06
Patient: female, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Diabetes Mellitus, Hypocalcaemia, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Lipitor
Administration route: Oral
Indication: Hypercholesterolaemia
Prednisone TAB
Zetia
Administration route: Oral
Indication: Hypercholesterolaemia
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-06-29
Patient: male, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Blood Creatine Phosphokinase Increased, Fear, Myalgia, Facial Paresis, Joint Range of Motion Decreased, Amyotrophic Lateral Sclerosis, Blood Cholesterol Increased, Dyspnoea, Pain in Extremity, Chromaturia, Anxiety, Hyperphagia, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypercholesterolaemia
Lipitor
Indication: Blood Cholesterol Increased
Zetia
Other drugs received by patient: Norvasc; Metoprolol Succinate
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-06-25
Patient: male, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Blood Creatine Phosphokinase Increased, Dyspnoea, Pain in Extremity, Fear, Myalgia, Anxiety, Facial Paresis, Hyperphagia, Joint Range of Motion Decreased, Amyotrophic Lateral Sclerosis, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypercholesterolaemia
Lipitor
Indication: Blood Cholesterol Increased
Zetia
Other drugs received by patient: Norvasc; Metoprolol Succinate
Adverse event in 42 year old female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from United States on 2007-06-25
Patient: 42 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Crestor
Administration route: Oral
Tricor
Zetia
Other drugs received by patient: Darvocet; Neurontin
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-05-31
Patient: female, weighing 103.9 kg (228.5 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Myopathy, Muscle Spasms
Suspect drug(s):
Tricor
Dosage: 145 mg daily po
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2006-10-04
End date: 2007-05-25
Zetia
Dosage: 10 mg daily po
Administration route: Oral
Indication: Drug Ineffective
Start date: 2006-11-15
End date: 2007-05-25
Zetia
Dosage: 10 mg daily po
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2006-11-15
End date: 2007-05-25
Other drugs received by patient: Hydrochlorothiazide; Metformin HCL; Prilosec
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-05-22
Patient: male, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Blood Creatine Phosphokinase Increased, Dyspnoea, Pain in Extremity, Fear, Myalgia, Facial Paresis, Hyperphagia, Joint Range of Motion Decreased, Amyotrophic Lateral Sclerosis, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypercholesterolaemia
Lipitor
Indication: Blood Cholesterol Increased
Zetia
Other drugs received by patient: Norvasc; Metoprolol Succinate
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-05-18
Patient: female
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 42 year old male receiving Zetia (Ezetimibe)
Reported by a consumer/non-health professional from France on 2007-05-15
Patient: 42 year old male, weighing 105.0 kg (231.0 pounds)
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Tachycardia, Muscular Weakness
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-05-07
Patient: male
Adverse reactions / side effects: Myalgia, Weight Decreased, Blood Creatine Phosphokinase Increased, Muscle Atrophy, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Indication: Hypercholesterolaemia
Zetia
Adverse event in 16 year old female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from Italy on 2007-04-20
Patient: 16 year old female, weighing 51.7 kg (113.8 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Blood Thyroid Stimulating Hormone Increased, Varicella
Suspect drug(s):
Zetia
Dosage: 10 mg/daily/po
Administration route: Oral
Start date: 2006-09-27
End date: 2007-02-13
Zocor
Dosage: 10 mg/daily/po
Administration route: Oral
Start date: 2006-09-27
End date: 2007-02-13
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-04-18
Patient: female
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 42 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United Arab Emirates on 2007-04-18
Patient: 42 year old male, weighing 162.0 kg (356.4 pounds)
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Hepatic Enzyme Increased
Adverse event resulted in: disablity
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 16 year old female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from Italy on 2007-03-26
Patient: 16 year old female, weighing 61.7 kg (135.7 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Blood Thyroid Stimulating Hormone Increased, Varicella
Suspect drug(s):
Zetia
Dosage: 10 mg/daily/po
Administration route: Oral
Indication: Type IIA Hyperlipidaemia
Start date: 2006-09-27
End date: 2007-02-13
Zocor
Dosage: 10 mg/daily/po
Administration route: Oral
Indication: Type IIA Hyperlipidaemia
Start date: 2006-09-27
End date: 2007-02-13
Adverse event in 68 year old female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-03-20
Patient: 68 year old female
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Blood Creatinine Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia
Administration route: Oral
Indication: Hypercholesterolaemia
Zocor
Administration route: Oral
Indication: Hypercholesterolaemia
Other drugs received by patient: Vytorin; Amiodarone Hydrochloride; Aspirin; Plavix; Xanax; Allopurinol; Synthroid; Toprol-XL; Demadex; Diovan; Lexapro
Adverse event in 16 year old female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from Italy on 2007-03-14
Patient: 16 year old female, weighing 61.7 kg (135.7 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Blood Thyroid Stimulating Hormone Increased
Suspect drug(s):
Zetia
Dosage: 10 mg/daily/po
Administration route: Oral
Start date: 2006-09-27
End date: 2007-02-13
Zocor
Dosage: 10 mg/daily/po
Administration route: Oral
Start date: 2006-09-27
End date: 2007-02-13
Adverse event in 16 year old female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from United States on 2007-03-14
Patient: 16 year old female, weighing 61.7 kg (135.7 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Blood Thyroid Stimulating Hormone Increased
Suspect drug(s):
Zetia
Dosage: 10 mg/daily/po
Administration route: Oral
Start date: 2007-02-08
End date: 2007-02-13
Zocor
Dosage: 40 mg/daily/po
Administration route: Oral
Start date: 2006-02-08
End date: 2006-02-13
Adverse event in 16 year old female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from Italy on 2007-03-05
Patient: 16 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Blood Thyroid Stimulating Hormone Increased
Suspect drug(s):
Zetia
Dosage: 10 mg/daily
Administration route: Oral
Indication: Type IIA Hyperlipidaemia
Start date: 2007-02-08
End date: 2007-02-13
Zocor
Dosage: 40 mg/daily
Administration route: Oral
Indication: Type IIA Hyperlipidaemia
Start date: 2006-02-06
End date: 2006-02-13
Adverse event in 72 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-03-02
Patient: 72 year old male
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Aldolase Increased, Asthenia
Suspect drug(s):
Crestor
Administration route: Oral
Zetia
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-02-07
Patient: male
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Muscular Weakness
Adverse event resulted in: disablity
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 51 year old male receiving Zetia (Ezetimibe)
Reported by a consumer/non-health professional from United States on 2007-01-31
Patient: 51 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Vertigo
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Lipitor; Aspirin; Niacin; Omega-3 Marine Triglycerides
Adverse event in 70 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Canada on 2007-01-24
Patient: 70 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Dyspnoea, Rhabdomyolysis, Hyperkalaemia, Hyperphosphataemia, Urinary Tract Infection, General Physical Health Deterioration, Haemoglobin Decreased, Malaise, Renal Tubular Necrosis, Muscle Spasms, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Rosuvastatin Calcium
Administration route: Oral
Start date: 2005-07-01
End date: 2006-04-01
Rosuvastatin Calcium
Administration route: Oral
Start date: 2005-03-20
End date: 2005-07-01
Zetia
Administration route: Oral
Start date: 2006-02-01
End date: 2006-04-01
Zetia
Administration route: Oral
Start date: 2006-04-01
Other drugs received by patient: Valsartan; Aspirin; Hydrochlorothiazide; Atenolol; Atenolol; Dimenhydrinate; Aspirin and Caffeine, Citrated and Codeine Phosphate; Aspirin and Caffeine, Citrated and Codeine Phosphate
Page 1 Next >>
|
